Duke University
Susan G. Komen presents Brinker Awards to breast cancer researchers
Susan G. Komen selected two breast cancer researchers to receive Brinker Awards, the nonprofit organization’s highest scientific honor.
Tap water avoidance protocol decreases rate of hospital-onset pulmonary NTM
The implementation of a tap water avoidance protocol in four units at Duke University Hospital reduced overall pulmonary nontuberculous mycobacteria acquisition by 76%, according to study data published in Clinical Infectious Diseases.
FDA seeks more data about cell therapy for pediatric GVHD
The FDA issued a complete response letter to a biologics license application that seeks approval of remestemcel-L to treat certain children with graft-versus-host disease.
Total ankle arthroplasty achieves stable ankle platform in patients with stage 4 flatfoot
In high-risk younger patients, cholesterol guideline suitability questioned
A new paper has questioned whether the 2018 American College of Cardiology/American Heart Association Guideline on the Management of Blood Cholesterol appropriately identifies younger high-risk patients as candidates for statin therapy.
Significant link found between frequent nightmares, CVD
U.S. veterans who had at least two nightmares a week were more likely to report having one of several cardiovascular conditions, data show.
Telehealth-based exams noninferior to traditional means for rotator cuff tear diagnosis
Chemicals in e-cigarettes may form toxic compounds
Flavorings combine with solvents in electronic cigarettes to produce unstable chemicals that may cause respiratory effects in users, according to new data presented at the virtual European Respiratory Society International Congress.
No clinical benefit of ACE inhibitor, ARB suspension in mild to moderate COVID-19
In patients hospitalized with mild or moderate COVID-19, suspending ACE inhibitors and angiotensin receptor blockers for 30 days, compared with continued treatment, did not impact the number of days alive and out of hospital.
Invasive approach to stable ischemic heart disease may benefit in HF, LV dysfunction
Patients with stable ischemic heart disease and HF and/or left ventricular dysfunction experienced worse outcomes compared with patients who did not and may benefit more from invasive treatment strategies, researchers reported.